Home / Stocks / TITANBIO
Back to all stocks
BSE · TITANBIO

Titan Bio-Tech Ltd.

Sector: Healthcare · ISIN: INE150C01029

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,301
of 5,004 stocks
▼ 111W
Peak #1,290 · 21 Sep 2026

Titan Bio-Tech Ltd., a smallcap Healthcare business, carries a steep earnings multiple that prices in strong future growth, is growing revenue rapidly, and earns a healthy return on equity. Ownership as of Jun 2026.

Market Cap
1,626.92 Cr
P/E Ratio
54.46
P/B Ratio
8.96
ROE
16.46%
ROCE
20.80%
Dividend Yield
—
52W High
—
52W Low
—

Quarterly financials

MetricQ1 2026-27Q4 2025-26Q3 2025-26Q2 2025-26
Revenue59.17 Cr48.83 Cr56.51 Cr54.35 Cr
Net Profit10.86 Cr6.73 Cr8.53 Cr7.76 Cr
EPS2.631.6310.329.40
Operating Profit12.93 Cr10.52 Cr10.82 Cr9.44 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter
55.78%
Public
44.22%

PUBLIC BREAKDOWN

DII
0.01%
Individuals
29.58%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-DateTypeDetails
20 Feb 2026SplitStock Split From Rs.10/- to Rs.2/-
19 Sep 2025DividendFinal Dividend - Rs. - 2.0000
23 Sep 2024DividendDividend - Rs. - 2.0000
22 Sep 2023DividendFinal Dividend - Rs. - 1.8000
22 Sep 2022DividendFinal Dividend - Rs. - 1.5000

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs